Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: Results of a retrospective multicenter study

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: Results of a retrospective multicenter study
Type de publicationJournal Article
Year of Publication2014
AuteursRaimond E, Ballester M, Hudry D, Bendifallah S, Darai E, Graesslin O, Coutant C.
JournalGYNECOLOGIC ONCOLOGY
Volume133
Pagination506-511
Date PublishedJUN
Type of ArticleArticle
ISSN0090-8258
Mots-clésadjuvant therapy, endometrial cancer, Sentinel lymph node biopsy
Résumé

{Objective. The aim of this study is to assess the impact of sentinel lymph node (SLN) mapping and ultrastaging on the therapeutic management of early-stage endometrial cancer. Methods. This retrospective multicenter study covered the period from January 2000 through December 2012 and included 304 women with presumed low- or intermediate-risk endometrial cancer. Node staging, histology results, and the effects of both on therapeutic management were assessed in two groups: those who underwent the SLN mapping and ultrastaging procedure and those treated in accordance with French guidelines. Results. The SLN procedure detected metastatic lymph nodes in three times more women than lymphadenectomy did (16.2% versus 5.1%

DOI10.1016/j.ygyno.2014.03.019